Liver disease in alcohol abusers: clinical perspective

被引:118
作者
Diehl, AM [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD 21205 USA
关键词
alcoholic fatty liver; hepatitis; cirrhosis; prognosis; treatment;
D O I
10.1016/S0741-8329(02)00204-5
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Alcoholic liver disease remains one of the most common causes of chronic liver disease in the world. The severity of liver damage related to alcohol varies among different individuals and even within any given individual at different times. Certain symptoms, signs, and abnormal findings on laboratory tests help clinicians distinguish among the various stages of alcohol-induced liver damage and, thus, have some prognostic significance. However, because all stages of this disease can persist for decades without causing overt evidence of serious liver damage, liver biopsy is the only test that can reliably distinguish among the various stages of alcohol-induced liver damage in many patients. The therapy of alcohol-induced liver disease varies according to the severity of histologic liver damage and clinically overt portal hypertension and hepatic dysfunction. Abstinence from alcohol consumption improves the clinical outcome of all stages of alcoholic liver disease. However, only two agents have proved to lesson early mortality in patients who require hospitalization for acutely decompensated alcoholic liver disease. It is not known whether either of these agents or other treatments prevent the development of alcohol-induced cirrhosis or improve the survival of patients who have already developed cirrhosis. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 17 条
  • [1] Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
    Akriviadis, E
    Botla, R
    Briggs, W
    Han, S
    Reynolds, T
    Shakil, O
    [J]. GASTROENTEROLOGY, 2000, 119 (06) : 1637 - 1648
  • [2] CARITHERS RL, 1989, ANN INTERN MED, V110, P658
  • [3] GALAMBOS JT, 1972, GASTROENTEROLOGY, V63, P1026
  • [4] PRIMARY NONFUNCTION OF FATTY LIVERS PRODUCED BY ALCOHOL IS ASSOCIATED WITH A NEW, ANTIOXIDANT-INSENSITIVE FREE-RADICAL SPECIES
    GAO, WS
    CONNOR, HD
    LEMASTERS, JJ
    MASON, RP
    THURMAN, RG
    [J]. TRANSPLANTATION, 1995, 59 (05) : 674 - 679
  • [5] COMPENSATED CIRRHOSIS - NATURAL-HISTORY AND PROGNOSTIC FACTORS
    GINES, P
    QUINTERO, E
    ARROYO, V
    TERES, J
    BRUGUERA, M
    RIMOLA, A
    CABALLERIA, J
    RODES, J
    ROZMAN, C
    [J]. HEPATOLOGY, 1987, 7 (01) : 122 - 128
  • [6] DO CORTICOSTEROIDS REDUCE MORTALITY FROM ALCOHOLIC HEPATITIS - A METAANALYSIS OF THE RANDOMIZED TRIALS
    IMPERIALE, TF
    MCCULLOUGH, AJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 113 (04) : 299 - 307
  • [7] COLCHICINE IN THE TREATMENT OF CIRRHOSIS OF THE LIVER
    KERSHENOBICH, D
    VARGAS, F
    GARCIATSAO, G
    TAMAYO, RP
    GENT, M
    ROJKIND, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (26) : 1709 - 1713
  • [8] RECOGNITION OF ALCOHOLIC LIVER-DISEASE IN A DISTRICT GENERAL-HOSPITAL
    LEVI, AJ
    CHALMERS, DM
    [J]. GUT, 1978, 19 (06) : 521 - 525
  • [9] HISTOLOGIC SPECTRUM OF ALCOHOLIC LIVER-DISEASE
    MACSWEEN, RNM
    BURT, AD
    [J]. SEMINARS IN LIVER DISEASE, 1986, 6 (03) : 221 - 232
  • [10] CYTOKINES AND ALCOHOLIC LIVER-DISEASE
    MCCLAIN, C
    HILL, D
    SCHMIDT, J
    DIEHL, AM
    [J]. SEMINARS IN LIVER DISEASE, 1993, 13 (02) : 170 - 182